 |
Previous Article | Next Article 
The Journal of Neuroscience, March 15, 1999, 19(6):2181-2186
Role of Protein Kinase A in the Maintenance of Inflammatory
Pain
Kochuvelikakam O.
Aley and
Jon D.
Levine
Departments of Anatomy, Medicine, and Oral Surgery, Neuroscience
and Biomedical Sciences Graduate Programs, National Institutes of
Health Pain Center, University of California, San Francisco, California
94143-0440
Although the initiation of inflammatory pain (hyperalgesia) has
been demonstrated to require the cAMP second messenger signaling cascade, whether this mechanism and/or other mechanisms underlie the
continued maintenance of the induced hyperalgesia is unknown. We report
that injection of adenylyl cyclase inhibitors before but not after
injection of direct-acting hyperalgesic agents (prostaglandin E2 and purine and serotonin receptor agonists) resulted in
reduction in hyperalgesia, evaluated by the Randall-Selitto
paw-withdrawal test. In contrast, injection of protein kinase A (PKA)
inhibitors either before or after these hyperalgesic agents resulted in
reduced hyperalgesia, suggesting that hyperalgesia after its activation was maintained by persistent PKA activity but not by adenylyl cyclase
activity. To evaluate further the role of PKA activity in the
maintenance of hyperalgesia, we injected the catalytic subunit of PKA
(PKACS) that resulted in hyperalgesia similar in magnitude to that
induced by the direct-acting hyperalgesic agents but much longer in
duration (>48 vs 2 hr). Injection of WIPTIDE (a PKA inhibitor)
at 24 hr after PKACS reduced hyperalgesia, suggesting that PKACS
hyperalgesia is not independently maintained by steps downstream from
PKA. In summary, our results indicate that, once established,
inflammatory mediator-induced hyperalgesia is no longer maintained by
adenylyl cyclase activity but rather is dependent on ongoing PKA
activity. An understanding of the mechanism maintaining hyperalgesia
may provide important insight into targets for the treatment of
persistent pain.
Key words:
adenylyl cyclase; cAMP; hyperalgesia; pain; protein
kinase A; prostaglandin E2
Copyright © 1999 Society for Neuroscience 0270-6474/99/1962181-06$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
F. A. Amaral, D. Sachs, V. V. Costa, C. T. Fagundes, D. Cisalpino, T. M. Cunha, S. H. Ferreira, F. Q. Cunha, T. A. Silva, J. R. Nicoli, et al.
Commensal microbiota is fundamental for the development of inflammatory pain
PNAS,
February 12, 2008;
105(6):
2193 - 2197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Napimoga, G. R. Souza, T. M. Cunha, L. F. Ferrari, J. T. Clemente-Napimoga, C. A. Parada, W. A. Verri Jr., F. Q. Cunha, and S. H. Ferreira
15d-Prostaglandin J2 Inhibits Inflammatory Hypernociception: Involvement of Peripheral Opioid Receptor
J. Pharmacol. Exp. Ther.,
January 1, 2008;
324(1):
313 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-H. Zheng, E. T. Walters, and X.-J. Song
Dissociation of Dorsal Root Ganglion Neurons Induces Hyperexcitability That Is Maintained by Increased Responsiveness to cAMP and cGMP
J Neurophysiol,
January 1, 2007;
97(1):
15 - 25.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-G. Zhao, S. W Ko, L.-J. Wu, H. Toyoda, H. Xu, J. Quan, J. Li, Y. Jia, M. Ren, Z. C. Xu, et al.
Enhanced Presynaptic Neurotransmitter Release in the Anterior Cingulate Cortex of Mice with Chronic Pain.
J. Neurosci.,
August 30, 2006;
26(35):
8923 - 8930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Alessandri-Haber, O. A. Dina, E. K. Joseph, D. Reichling, and J. D. Levine
A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators.
J. Neurosci.,
April 5, 2006;
26(14):
3864 - 3874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-J. Song, Z.-B. Wang, Q. Gan, and E. T. Walters
cAMP and cGMP Contribute to Sensory Neuron Hyperexcitability and Hyperalgesia in Rats With Dorsal Root Ganglia Compression
J Neurophysiol,
January 1, 2006;
95(1):
479 - 492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Otuki, J. Ferreira, F. V. Lima, C. Meyre-Silva, A. Malheiros, L. A. Muller, G. S. Cani, A. R. S. Santos, R. A. Yunes, and J. B. Calixto
Antinociceptive Properties of Mixture of {alpha}-Amyrin and {beta}-Amyrin Triterpenes: Evidence for Participation of Protein Kinase C and Protein Kinase A Pathways
J. Pharmacol. Exp. Ther.,
April 1, 2005;
313(1):
310 - 318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Liu, T. Yang, M. J. Bruno, O. S. Andersen, and S. A. Simon
Voltage-Gated Ion Channels in Nociceptors: Modulation by cGMP
J Neurophysiol,
October 1, 2004;
92(4):
2323 - 2332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-Y. Zhuang, H. Xu, D. E. Clapham, and R.-R. Ji
Phosphatidylinositol 3-Kinase Activates ERK in Primary Sensory Neurons and Mediates Inflammatory Heat Hyperalgesia through TRPV1 Sensitization
J. Neurosci.,
September 22, 2004;
24(38):
8300 - 8309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Deval, M. Salinas, A. Baron, E. Lingueglia, and M. Lazdunski
ASIC2b-dependent Regulation of ASIC3, an Essential Acid-sensing Ion Channel Subunit in Sensory Neurons via the Partner Protein PICK-1
J. Biol. Chem.,
May 7, 2004;
279(19):
19531 - 19539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sachs, F. Q. Cunha, and S. H. Ferreira
Peripheral analgesic blockade of hypernociception: Activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway
PNAS,
March 9, 2004;
101(10):
3680 - 3685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S B McMahon
Sensitisation of gastrointestinal tract afferents
Gut,
March 1, 2004;
53(90002):
ii13 - 15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Zhang, H. Li, B. Liu, and S. J. Brull
Acute Topical Application of Tumor Necrosis Factor alpha Evokes Protein Kinase A-Dependent Responses in Rat Sensory Neurons
J Neurophysiol,
September 1, 2002;
88(3):
1387 - 1392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. O. Aley, A. Martin, T. McMahon, J. Mok, J. D. Levine, and R. O. Messing
Nociceptor Sensitization by Extracellular Signal-Regulated Kinases
J. Neurosci.,
September 1, 2001;
21(17):
6933 - 6939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Carruthers, L. A. Sellers, D. W. Jenkins, E. M. Jarvie, W. Feniuk, and P. P. A. Humphrey
Adenosine A1 Receptor-Mediated Inhibition of Protein Kinase A-Induced Calcitonin Gene-Related Peptide Release from Rat Trigeminal Neurons
Mol. Pharmacol.,
June 1, 2001;
59(6):
1533 - 1541.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Tominaga, M. Wada, and M. Masu
Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia
PNAS,
May 18, 2001;
(2001)
111025298.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Tominaga, M. Wada, and M. Masu
From the Cover: Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia
PNAS,
June 5, 2001;
98(12):
6951 - 6956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Levy and A. M. Strassman
Distinct sensitizing effects of the cAMP-PKA second messenger cascade on rat dural mechanonociceptors
J. Physiol.,
January 9, 2002;
538(2):
483 - 493.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|